Pharmacokinetics and Glucodynamics of LY900014 Compared to Insulin Lispro (Humalog) Following Single Dose Administration in Japanese Patients With Type 1 Diabetes Mellitus
Phase of Trial: Phase I
Latest Information Update: 20 Jul 2018
At a glance
- Drugs Insulin lispro (Primary)
- Indications Type 1 diabetes mellitus
- Focus Pharmacokinetics
- Sponsors Eli Lilly; Eli Lilly Japan
- 20 Jul 2018 Status changed from active, no longer recruiting to completed.
- 06 Jul 2018 Status changed from recruiting to active, no longer recruiting.
- 08 Jun 2018 Planned End Date changed from 1 Jun 2018 to 1 Jul 2018.